Bodensee Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient bexarotene ATC L01XF03 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Bodensee Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient bexarotene ATC L01XF03 for the period 01062024 - 31052026 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....